CymaBay Therapeutics has received a patent to treat NAFLD
CymaBay Therapeutics has received a patent to treat NAFLD and NASH with MBX-0825 by administering an amount that proves to be therapeutically effective orally. Read More »
FDA approves Lundbeck’s Carnexiv injection
Lundbeck's Carnexiv injection -- an orally administered replacement therapy for short-term use to treat adults with specific types of seizures -- has been approved by the U.S. Food and Drug Administration. Read More »
Corvus releases CPI-444 trial biomarker findings
Corvus Pharmaceuticals has released its biomarker findings in its ongoing Phase 1/1b clinical trial involving CPI-444, as both a single agent and as a combination with TECENTRIQ, a Genentech product that is a fully humanized monoclonal antibody developed to target cell death ligand 1 protein. Read More »
UnitedHealth Group releases third quarter results
UnitedHealth Group this week released its third quarter results, reporting that the company has experienced growth at a well-balanced level and steady execution in all areas of its various businesses. Read More »
Report: Medicaid could save billions using pharmacy benefit management tools
Medicaid could see $51.1 billion over the next decade if a “full range of pharmacy benefit management tools” is employed, according to a new report completed by The Menges Group and released by the Pharmaceutical Care Management Association (PCMA). Read More »
Pharmacy benefit management strategies result in more competition, lower costs, asserts PCMA president
Pharmacy benefit managers (PBMs) are proven in helping the control rising prescription drug prices and should be part of the solutions adopted by policymakers, writes Pharmaceutical Care Management Association (PCMA) President Mark Merritt in an op-ed published yesterday in The Hill. Read More »
U.S. patients pay less for Hepatitis C medication
Hepatitis C medication costs in 2015 proved lower for the U.S. than Europe and Japan, particularly prices negotiated by pharmacy benefit managers in Medicare Part D, the Pharmaceutical Care Management Association recently reported. Read More »
Nicox receives CRL from FDA for AC-170
The U.S. Food and Drug Administration has sent Nicox S.A. a Complete Response Letter in regard to its AC-170 New Drug Application. Read More »
Pfizer releases INLYTA trial data
Pfizer has released data from its Phase 1b INLYTA clinical trial in which the drug is combined with pembrolizumab, a PD-1 inhibitor called KEYTRUDA, and marketed by Merck. Read More »
The Medicines Co. releases updated ORION-1 trial information
The Medicines Co. recently released update information regarding its ORION-1 clinical trial, which revolves around PCSK9si, the company’s investigational PCSK9 synthesis inhibitor. Read More »
CVS Health awards WomenHeart community grant
WomenHeart: The National Coalition for Women with Heart Disease has received a community grant from CVS Health to help build healthier communities and support nonprofit organizations assisting underserved populations receive health care. Read More »
FDA accepts Coherus’ BLA for CHS-1701
Coherus BioSciences has filed of its 351(k) Biologics License Application for its pegfilgrastim biosimilar candidate CHS-1701 has been accepted by the U.S. Food and Drug Administration. Read More »
Allergan, DMRF continue collaboration to bring awareness to dystonia
Allergan will continue its collaborative efforts with Dystonia Medical Research Foundation to support patients with dystonia by conducting a survey that will assess cervical dystonia awareness, its symptoms and options for treatment that will inspire education and the correct diagnosis of the condition, which can often be disabling. Read More »
FDA approves two new dosing options for ZUBSOLV
.jpg)
The buprenorphine/naloxone CIII sublingual tablet ZUBSOLV from Orexo US has been approved by the U.S. Food and Drug Administration. Read More »
ZUMA-6 clinical trial enrolls first patient
Kite Pharma has enrolled its first patient into the Phase 1b/2 ZUMA-6 clinical trial involving KTE-C19. Read More »
CVS Health makes preparations for patients when hurricanes loom
In the wake of Hurricane Matthew, CVS Health reminds its customers to properly prepare their prescriptions and take care of their needs when storms are approaching their areas. Read More »
Walgreens reminds customers about prescription preparedness
In the wake of Hurricane Matthew bearing down on the East Coast, Walgreens is reminding its pharmacy patients about how important prescription preparedness is in times like these. Read More »
Catabasis Pharmaceuticals adds to two leadership team
Catabasis Pharmaceuticals' Andrew Nichols has been named the company’s new chief scientific officer and Angelika Fretzen has been named senior vice president of product development. Read More »
Preferred pharmacy plans rally in comeback
Recent data from the Baltimore, Maryland-based Centers for Medicare & Medicaid Services (CMS) suggests that over eight out of ten Medicare Part D regional prescription drug plans (PDP) will utilize preferred network plans in 2017. Read More »
Eli Lilly to present data at European Society of Medical Oncology Congress
Eli Lilly and Co. will present data at the European Society of Medical Oncology’s 2016 Congress in Copenhagen from a number of clinical studies that will serve to further strengthen the development of its diverse clinical cancer portfolio. Read More »
Alerts Sign-up